Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Guided Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -303.8%. For fiscal 2025 it was -309.3%, against -30114.3% the year before. The highest annual figure on record is -48.2% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -309.3% | +29805.0 |
| FY2024 | Dec 31, 2024 | -30114.3% | −26586.7 |
| FY2023 | Dec 31, 2023 | -3527.6% | +22110.9 |
| FY2022 | Dec 31, 2022 | -25638.5% | −22722.4 |
| FY2021 | Dec 31, 2021 | -2916.0% | −1884.7 |
| FY2020 | Dec 31, 2020 | -1031.4% | +1571.4 |
| FY2019 | Dec 31, 2019 | -2602.8% | +113.0 |
| FY2018 | Dec 31, 2018 | -2715.8% | −1436.7 |
| FY2017 | Dec 31, 2017 | -1279.1% | +13547.1 |
| FY2015 | Dec 31, 2015 | -14826.2% | −1489.3 |
| FY2014 | Dec 31, 2014 | -13336.9% | −12531.3 |
| FY2013 | Dec 31, 2013 | -805.6% | −677.4 |
| FY2012 | Dec 31, 2012 | -128.3% | +59.6 |
| FY2011 | Dec 31, 2011 | -187.8% | −139.6 |
| FY2010 | Dec 31, 2010 | -48.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -120.3% | +5863.0 |
| Q3 FY2025 | Sep 30, 2025 | -808.3% | +707.3 |
| Q2 FY2025 | Jun 30, 2025 | -652.1% | +2768.3 |
| Q4 FY2024 | Dec 31, 2024 | -53400.0% | −49568.2 |
| Q1 FY2024 | Mar 31, 2024 | -5983.3% | +34816.7 |
| Q4 FY2023 | Dec 31, 2023 | -1515.6% | +12824.4 |
| Q2 FY2023 | Jun 30, 2023 | -3420.5% | +5439.5 |
| Q1 FY2023 | Mar 31, 2023 | -3831.8% | −3106.8 |
| Q3 FY2022 | Sep 30, 2022 | -40800.0% | −38236.8 |
| Q2 FY2022 | Jun 30, 2022 | -14340.0% | +13710.0 |
| Q1 FY2022 | Mar 31, 2022 | -8860.0% | −7708.0 |
| Q4 FY2021 | Dec 31, 2021 | -725.0% | −526.3 |
| Q3 FY2021 | Sep 30, 2021 | -2563.2% | −1531.9 |
| Q2 FY2021 | Jun 30, 2021 | -28050.0% | −9250.0 |
| Q4 FY2020 | Dec 31, 2020 | -1152.0% | +31548.0 |
| Q3 FY2020 | Sep 30, 2020 | -198.7% | +1229.1 |
| Q4 FY2019 | Dec 31, 2019 | -1031.3% | +37.8 |
| Q3 FY2019 | Sep 30, 2019 | -18800.0% | −7100.0 |
| Q2 FY2019 | Jun 30, 2019 | -32700.0% | −26562.5 |
| Q1 FY2019 | Mar 31, 2019 | -1427.8% | +7972.2 |
| Q4 FY2018 | Dec 31, 2018 | -1069.0% | −385.9 |
| Q3 FY2018 | Sep 30, 2018 | -11700.0% | −7642.4 |
| Q2 FY2018 | Jun 30, 2018 | -6137.5% | −5524.9 |
| Q1 FY2018 | Mar 31, 2018 | -9400.0% | −6952.4 |
| Q4 FY2017 | Dec 31, 2017 | -683.2% | +31.6 |
| Q3 FY2017 | Sep 30, 2017 | -4057.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -612.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -2447.6% | – |
| Q3 FY2016 | Sep 30, 2016 | -714.7% | – |
See a number that looks wrong?